StockData
Sionna Therapeutics, Inc. logo

Sionna Therapeutics, Inc. (SION) stock

SIONNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30
$3.07−0.05 (-1.60%)

Close on Nov 17, 2026Market cap $138.80MP/E –Yield –

Sionna Therapeutics operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Sionna Therapeutics's operating cash flow for the twelve months ending Sep 30, 2026 was -$79.41M. For fiscal 2025 it was -$66.30M.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$66.30M–
FY2024Dec 31, 2024-$52.79M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$18.72M–
Q2 FY2026Jun 30, 2026-$22.22M–
Q1 FY2026Mar 31, 2026-$21.84M–
Q4 FY2025Dec 31, 2025-$16.63M–
Q3 FY2025Sep 30, 2025-$15.23M–
Q2 FY2025Jun 30, 2025-$18.15M–
Q1 FY2025Mar 31, 2025-$16.29M–
Q4 FY2024Dec 31, 2024-$11.78M–
Q3 FY2024Sep 30, 2024-$17.69M–
Q2 FY2024Jun 30, 2024-$10.15M–
Q1 FY2024Mar 31, 2024-$13.18M–

More Sionna Therapeutics figures

See a number that looks wrong?